[1] |
Ferlay J, Shin H R, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 12 7(12): 2893-917.
|
[2] |
Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer[J]. Semin Radiat Oncol, 2007, 17(1): 2-9.
|
[3] |
Jemal A, Bray F, Center M M, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
|
[4] |
Liu LH, Meng J, Zhang C, et al. Serum protein fingerprint diagnoic patterns was estaslished by MALDI-TOF MS for human esophagial carcinoma[J]. Zhong Liu Fang Zhi Yan Jiu, 2012, 39 (2): 169-72. [刘丽华, 孟君, 张璁, 等. 运用MALDI-TOF MS方 法建立食管癌患者血清蛋白指纹图谱诊断模型[J]. 肿瘤防治研 究, 2012, 39(2): 169-72.]
|
[5] |
Pennathur A, Luketich J D. Resection for esophageal cancer: strategies for optimal management[J]. Ann Thorac Surg, 2008, 85 (2): S751-6.
|
[6] |
Lin Y, Chen JQ, Li JC, et al. Value of postoperative radiochemotherapy for thoracic esophageal squamous cell carcinoma with lymph node metastasis[J]. Zhonghua Zhong Liu Za Zhi, 2014, 36(2): 151-4. [林宇, 陈俊强, 李建成, 等. 淋巴结 阳性胸段食管鳞癌术后放化疗的价值[J]. 中华肿瘤杂志, 2014, 36 (2): 151-4.]
|
[7] |
Allum WH, Stenning SP, Bancewicz J, et al. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer[J]. J Clin Oncol, 2009, 27 (30): 5062-7.
|
[8] |
Spinosa EJ, Carvalho AC. Support vector machines for novel class detection in bioinformatics[J]. Genet Mol Res, 2005, 4(3): 608-15.
|
[9] |
Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma[J]. Lancet, 2013, 381(9864): 400-12.
|
[10] |
Wang H, Huang G. Application of support vector machine in cancer diagnosis[J]. Med Oncol, 2010, 28(Suppl1): s613-8.
|
[11] |
Wang SJ, Zhang LW, Yu WF, et al. Establishment of a diagnostic model of serum protein fingerprint pattern for esophageal cancer screening in high incidence area and its clinical value [J]. Zhonghua Zhong Liu Za Zhi 2007, 29(2): 441-3. [王士杰, 张立玮, 于卫芳, 等. 高发区筛查人群食管鳞癌血清蛋白指纹图谱诊断 模型的建立及临床价值[J]. 中华肿瘤杂志, 2007, 29(6): 441-3.]
|
[12] |
Hermeking H. The 14-3-3 cancer connection[J]. Nat Rev Cancer, 20 03, 3(12): 931-43.
|
[13] |
Dougherty MK, Morrison DK. Unlocking the code of 14-3-3[J]. J Cell Sci, 2004, 117(10): 1875-84.
|
[14] |
Mackintosh C. Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes[J]. Biochem J, 20 04, 381(2): 329-42.
|
[15] |
Freeman AK, Morrison DK. 14-3-3 Proteins: diverse functions in cell proliferation and cancer progression[J]. Semin Cell Dev Biol, 20 11, 22(7): 681-7.
|
[16] |
Iacobuzio-Donahue CA, Ashfaq R, Maitra A, et al. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies[J]. Cancer Res, 2003, 63(24): 8614-22.
|
[17] |
Perathoner A, Pirkebner D, Brandacher G, et al. 14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients[J]. Clin Cancer Res, 20 05, 11(9): 3274-9.
|
[18] |
Shiba-Ishii A, Noguchi M. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma[J]. Am J Pathol, 2012, 180(4): 1653-62.
|
[19] |
Shiba-Ishii A, Kano J, Morishita Y, et al. High expression of stratifin is a universal abnormality during the course of malignant progression of early-stage lung adenocarcinoma[J]. Int J Cancer, 20 11, 129(10): 2445-53.
|
[20] |
Okumura H, Kita Y, Yokomakura N, et al. Nuclear expression of 14 -3-3 sigma is related to prognosis in patients with esophageal squamous cell carcinoma[J]. Anticancer Res, 2010, 30(12): 5175-9.
|
[21] |
Ren HZ, Pan GQ, Wang JS, et al. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma[J]. Dig Dis Sci, 2010, 55(9): 2552-60.
|
[22] |
Wang X P, Wang Q X, Lin H P, et al. Significance of clinicopathology and expression of heat shock protein 72 and glycoprotein 96 in human hepatocellular carcinoma[J]. Afr J Microbiol Res, 2011, 5(31): 5607-14.
|
[23] |
Wang XP, Wang QX, Ying XP, et al. Correlation between clinicopathology and expression of heat shock protein 72 and glycoprotein 96 in human gastric adenocarcinoma[J]. Tohoku J Exp Med, 2007, 212(1): 35-41.
|
[24] |
Zheng HC, Takahashi H, Li XH, et al. Overexpression of GRP78 and GRP94 are markers for aggressive hehavior and poor progonosis in gastric carcinoma[J]. Hum Pathol, 2008, 39(7): 10 42-9.
|
[25] |
Wang XP, Wang QX, Guo LS, et al. Immunolocalization of heat shock protein 72 and glycoprotein 96 in colonic adenocarcinoma[J]. Acta Histochem, 2008, 110(2): 117-23.
|
[26] |
Wang X, Wang Q, Lin H. Correlation between clinicopathology and expression of heat shock protein 72 and glycoprotein 96 in human esophageal squamous cell carcinoma[J]. Clin Dev Immunol, 2010, 2010: 212537.
|
[27] |
Wang XP, Liu GZ, Song AL, et al. Expression and significance of heat shock protein 70 and glucose-regulated protein 94 in human esophageal cancer[J]. World J Gastroenterol, 2005, 11(3): 429-32.
|
[28] |
Wang Q, An L, Chen Y, et al. Expression of endoplasmic reticulum molecular chaperon GRP94 in human lung cancer tissues and its clinical significance[J]. Chin Med J (Engl), 2002, 115(11): 1615-9.
|
[29] |
Lin CY, Lin TY, Wang HM, et al. GP96 is over-expressed in oral cavity cancer and is a poor prognostic indicator for patients rece iving radiotherapy[J]. Radiat Oncol, 2011, 6:136.
|